IP Library › Granted Patent US 10,513,624
Granted Patent B2
US 10,513,624 · App. 16/099,305 · Granted Dec 24, 2019

Active ray-curable inkjet ink and image forming method

Inventor: Takayuki Toeda (Tokyo, JP)
Assignee: KONICA MINOLTA, INC.
C09D11/38B41M7/0081C09D11/322
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,513,624
App. No.
16/099,305
Granted
Dec 24, 2019
Kind
B2
Abstract

The present invention relates to: an active ray-curable inkjet ink which has high gloss and is capable of forming an image that is suppressed in gloss difference between itself and a base; and an image forming method which uses this active ray-curable inkjet ink. An active ray-curable inkjet ink according to the present invention contains a photopolymerizable compound, a photoinitiator and a crystalline gelling agent, and is capable of undergoing a sol-gel phase transition. This active ray-curable inkjet ink is characterized by additionally containing a fluorescent bleaching agent.

Claims (17)

1. An actinic radiation-curable inkjet ink capable of undergoing sol-gel phase transition, comprising a photocurable compound, a photopolymerization initiator and a crystalline gelling agent,

wherein the actinic radiation-curable inkjet ink further comprises a fluorescent brightener, and the fluorescent brightener is dissolved in the ink.

2. The actinic radiation-curable inkjet ink according to claim 1 , wherein a content of the fluorescent brightener is 0.01 mass % or more and 1.0 mass % or less with respect to a total mass of the actinic radiation-curable inkjet ink.

3. The actinic radiation-curable inkjet ink according to claim 1 , wherein the fluorescent brightener contains a compound represented by the following general formula (1):

wherein R 1 to R 8 each independently represent a hydrogen atom or an alkyl group, and

A represents a linking group represented by any of the following formulas (2) to (5):

wherein each * represents a bonding position of A in each formula.

4. The actinic radiation-curable inkjet ink according to claim 1 , wherein a content of the crystalline gelling agent is 1 mass % or more and 10 mass % or less with respect to a total mass of the actinic radiation-curable inkjet ink.

5. The actinic radiation-curable inkjet ink according to claim 1 , wherein the crystalline gelling agent contains at least one selected from the group consisting of compounds represented by the following general formulas (G1) and (G2):

R 9 —CO—R 10   General formula (G1):

R 11 —COO—R 12   General formula (G2):

wherein R 9 to R 12 each independently represent a straight chain or branched chain hydrocarbon group having 9 or more and 25 or less carbon atoms.

6. The actinic radiation-curable inkjet ink according to claim 1 , further comprising a colorant.

7. The actinic radiation-curable inkjet ink according to claim 1 , wherein the fluorescent brightener is crystalized in the ink in a course of curing the photocurable compound.

8. An image forming method, comprising:

discharging the actinic radiation-curable inkjet ink according to claim 1 from a nozzle of an inkjet recording apparatus and causing the actinic radiation-curable inkjet ink to land on a substrate; and

curing the actinic radiation-curable inkjet ink by irradiating, with actinic radiation, the actinic radiation-curable inkjet ink landed on the substrate.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 6, 2018
From: TOEDA, TAKAYUKI
To: KONICA MINOLTA, INC.
Reel/Frame 047423/0640 →
Priority Claims (1)
JP 2016-120613 · Jun 17, 2016 · national
Continuity (1)
Related Publication 20190211222A1 · Jul 11, 2019
Cited By (1)
US 12,528,889